RANI THERAPEUTICS HOLDINGS INC. - CLASS A COMMON
2.4100
08-November-24 14:59:48
15 minutes delayed
Stocks
-0.1000
-3.98%
Today's range
2.3200 - 2.5400
ISIN
N/A
Source
NASDAQ
-
Rani Therapeutics to Participate in Upcoming Investor Conferences
07 Nov 2024 15:05:02 By Nasdaq GlobeNewswire
-
17 Oct 2024 07:00:00 By Nasdaq GlobeNewswire
-
15 Oct 2024 07:30:00 By Nasdaq GlobeNewswire
-
Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit
08 Oct 2024 15:05:00 By Nasdaq GlobeNewswire
-
Rani Therapeutics to Participate in September Investor Conferences
03 Sep 2024 15:05:00 By Nasdaq GlobeNewswire
-
Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update
06 Aug 2024 15:05:00 By Nasdaq GlobeNewswire
-
Rani Therapeutics to Participate in August Investor Conferences
29 Jul 2024 15:05:00 By Nasdaq GlobeNewswire
-
Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering
22 Jul 2024 07:30:00 By Nasdaq GlobeNewswire
-
Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment
24 Jun 2024 06:00:00 By Nasdaq GlobeNewswire
-
Rani Therapeutics to Participate in May Investor Conferences
14 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
09 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update
06 May 2024 15:05:00 By Nasdaq GlobeNewswire
-
20 Mar 2024 15:05:00 By Nasdaq GlobeNewswire
-
Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
15 Mar 2024 15:05:00 By Nasdaq GlobeNewswire
-
05 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
14 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
-
Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update
08 Nov 2023 15:05:02 By Nasdaq GlobeNewswire
-
01 Nov 2023 15:05:00 By Nasdaq GlobeNewswire
-
25 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
19 Oct 2023 15:05:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >